近日，美国加州大学戴维斯分校综合癌症中心的一个研究小组确定了 CD95 受体上一个可导致细胞死亡的关键表位。这种触发细胞程序性死亡的新能力可能会为改进癌症治疗打开大门。据科技日报报道，这一发现发表在近期《自然》杂志旗下的《细胞死亡与分化》杂志上。
根据该研究，CD95 受体被认为是癌细胞生死的关键因素。它的变化可能导致细胞死亡，从而影响癌细胞的生长和传播。这一发现为癌症治疗提供了新的可能性，有望为患者提供更有效的治疗方法。
加州大学戴维斯分校综合癌症中心的负责人表示：“我们很高兴发现了这个关键表位，它是我们研究癌症治疗的重要一步。我们期待着这一发现能够为癌症患者带来更好的治疗。”
据《自然》杂志旗下的《细胞死亡与分化》杂志发表的论文，该研究的主要作者包括加州大学戴维斯分校综合癌症中心的科学家和医生。他们使用了多种研究方法，包括蛋白质组学和细胞学技术，来确定 CD95 受体上的关键表位。
这一发现引起了学术界的高度关注。它提供了一个新的靶点，可以用于改进癌症治疗。科学家表示，下一步他们将研究如何利用 CD95 受体来治疗癌症。
新闻翻译：
Title: US California University study finds cancer cell’s death switch, cancer treatment may see significant improvements
Keywords: US California University, study, cancer cells, death switch, cancer treatment
News content: Recently, a research team at the University of California, Davis Comprehensive Cancer Center in the United States identified a key site on the CD95 receptor that can cause cell death. This new ability to trigger programmed cell death may open the door to more effective cancer treatments. According to a report by TechCrunch, this finding was published in the recent issue of the journal Cell Death and Differentiation from the Nature group.
According to this study, the CD95 receptor is considered the key factor in cancer cell survival and death. Its changes can cause cell death, affecting the growth and spread of cancer cells. This discovery provides a new possibility for cancer treatment and 有望为 patients 提供更有效的 methods.
The head of the University of California, Davis Comprehensive Cancer Center said, “We are delighted to have discovered this key site, which is an important step in our cancer treatment research. We look forward to seeing how this discovery can benefit cancer patients.”
The paper, co-authored by scientists and doctors at the University of California, Davis Comprehensive Cancer Center, was published in the recent issue of the journal Cell Death and Differentiation from the Nature group. They used a variety of research methods, including proteinomics and cell biology techniques, to identify the key site on the CD95 receptor.
This discovery has attracted significant attention from the academic community. It provides a new target for cancer treatment. Scientists say the next step will be to study how to use the CD95 receptor for cancer treatment.
【来源】https://www.zhihu.com/question/628526802
Views: 1